The evaluation of insulin sensitivity using the hyperinsulinemic–euglycemic clamp in patients newly diagnosed with T1DM and T2DM highlighted differences in plasma metabonomics between the two groups of patients. The gene discussed is INS; the disease is type 1 diabetes mellitus.